Palisade Bio

PALI64

Penny Stock

$3.98arrow_drop_up5.10%$0.19

Penny Stock

PALI64

$3.98

arrow_drop_up5.10%$0.19

Penny Stock

Performance History

Key Stats
Open	$3.88
Prev. Close	$3.79
EPS	-18.57
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$4.48M
PE Ratio	-

	LOW	HIGH
Day Range	3.80	4.12
52 Week Range	3.30	22.35

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-18.57

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Palisade Bio (PALI)

Palisade Bio, Inc., also known as PALI, is a biopharmaceutical company that focuses on the development and commercialization of novel treatments for gastrointestinal diseases. The company's mission is to improve the lives of patients by delivering innovative therapies that address unmet medical needs. PALI is committed to leveraging its deep understanding of the gut microbiome to develop targeted therapies that have the potential to transform patient care.

As of the latest stock price history, PALI has shown a volatile performance. Over the past year, the stock has traded within a 52-week range of $2.50 to $10.00. The day range for PALI is currently unavailable. The trading volume of PALI has varied significantly, reflecting the market's interest in the company.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. J. D. Finley
Headquarters: Carlsbad
Employees: 12
Exchange: NASDAQ

Keep an eye on Palisade Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Palisade Bio's (PALI) price per share?

The current price per share for Palisade Bio (PALI) is $3.87. The stock has seen a price change of $0.19 recently, indicating a 5.11% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Palisade Bio (PALI)?

For Palisade Bio (PALI), the 52-week high is $22.35, which is 461.06% from the current price. The 52-week low is $3.3, the current price is 20.71% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Palisade Bio (PALI) a growth stock?

Palisade Bio (PALI) has shown an average price growth of 0.41% over the past three years. It has received a score of 90 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Palisade Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Palisade Bio (PALI) stock price performance year to date (YTD)?

As of the latest data, Palisade Bio (PALI) has a year-to-date price change of -54.13%. Over the past month, the stock has experienced a price change of 7.37%. Over the last three months, the change has been -14.88%. Over the past six months, the figure is -26.33%.

help

Is Palisade Bio (PALI) a profitable company?

Palisade Bio (PALI) has a net income of -$12.32M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $246K. Operating income is noted at -$12.84M. Furthermore, the EBITDA is -$14.59M.

help

What is the market capitalization of Palisade Bio (PALI)?

Palisade Bio (PALI) has a market capitalization of $4.49M. The average daily trading volume is 20.95K, indicating the stock's liquidity and investor engagement.